Synopsis
0
EU WC
0
NDC API
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Su...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Inhaler solution
Dosage Strength : 250ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Inhaler solution
Dosage Strength : 100ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Inhaler solution
Dosage Strength : 50ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Regulatory FDF Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
Main Therapeutic Indication : Anaesthetic
Currency : USD
2017 Revenue in Millions : 410
2016 Revenue in Millions : 428
Growth (%) : -4
Main Therapeutic Indication : Anesthetics
Currency : USD
2016 Revenue in Millions : 428
2015 Revenue in Millions : 474
Growth (%) : -10
Main Therapeutic Indication : Others
Currency : USD
2015 Revenue in Millions : 550
2014 Revenue in Millions : 474
Growth (%) : -14%
Main Therapeutic Indication : Central Nervous System And Anesthes...
Currency : USD
2018 Revenue in Millions : 391
2017 Revenue in Millions : 410
Growth (%) : -5%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 348
2018 Revenue in Millions : 391
Growth (%) : -11
Main Therapeutic Indication : Others
Currency : USD
2014 Revenue in Millions : -3.20%
2013 Revenue in Millions :
Growth (%) :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
19 Feb 2025
Reply
30 Oct 2024
Reply
10 Aug 2024
Reply
31 Jan 2024
Reply
21 Jun 2022
Reply
02 Sep 2021
Reply
08 Feb 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
Reply
18 Dec 2023
Reply
11 Jul 2023
Reply
19 Jan 2021
Reply
28 Aug 2020
Reply
06 Jan 2020
Reply
07 Feb 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
EDQM
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]USP
JP
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
49
PharmaCompass offers a list of Sevoflurane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sevoflurane manufacturer or Sevoflurane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sevoflurane manufacturer or Sevoflurane supplier.
PharmaCompass also assists you with knowing the Sevoflurane API Price utilized in the formulation of products. Sevoflurane API Price is not always fixed or binding as the Sevoflurane Price is obtained through a variety of data sources. The Sevoflurane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sevoflurane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sevoflurane, including repackagers and relabelers. The FDA regulates Sevoflurane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sevoflurane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sevoflurane manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sevoflurane supplier is an individual or a company that provides Sevoflurane active pharmaceutical ingredient (API) or Sevoflurane finished formulations upon request. The Sevoflurane suppliers may include Sevoflurane API manufacturers, exporters, distributors and traders.
click here to find a list of Sevoflurane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sevoflurane DMF (Drug Master File) is a document detailing the whole manufacturing process of Sevoflurane active pharmaceutical ingredient (API) in detail. Different forms of Sevoflurane DMFs exist exist since differing nations have different regulations, such as Sevoflurane USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sevoflurane DMF submitted to regulatory agencies in the US is known as a USDMF. Sevoflurane USDMF includes data on Sevoflurane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sevoflurane USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sevoflurane suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sevoflurane Drug Master File in Japan (Sevoflurane JDMF) empowers Sevoflurane API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sevoflurane JDMF during the approval evaluation for pharmaceutical products. At the time of Sevoflurane JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sevoflurane suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sevoflurane Drug Master File in Korea (Sevoflurane KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sevoflurane. The MFDS reviews the Sevoflurane KDMF as part of the drug registration process and uses the information provided in the Sevoflurane KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sevoflurane KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sevoflurane API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sevoflurane suppliers with KDMF on PharmaCompass.
A Sevoflurane CEP of the European Pharmacopoeia monograph is often referred to as a Sevoflurane Certificate of Suitability (COS). The purpose of a Sevoflurane CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sevoflurane EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sevoflurane to their clients by showing that a Sevoflurane CEP has been issued for it. The manufacturer submits a Sevoflurane CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sevoflurane CEP holder for the record. Additionally, the data presented in the Sevoflurane CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sevoflurane DMF.
A Sevoflurane CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sevoflurane CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sevoflurane suppliers with CEP (COS) on PharmaCompass.
Sevoflurane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sevoflurane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sevoflurane GMP manufacturer or Sevoflurane GMP API supplier for your needs.
A Sevoflurane CoA (Certificate of Analysis) is a formal document that attests to Sevoflurane's compliance with Sevoflurane specifications and serves as a tool for batch-level quality control.
Sevoflurane CoA mostly includes findings from lab analyses of a specific batch. For each Sevoflurane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sevoflurane may be tested according to a variety of international standards, such as European Pharmacopoeia (Sevoflurane EP), Sevoflurane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sevoflurane USP).
Comment (2)
